This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Japan Science and Technology Corporation. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Masato Nakafuku: Innovator in Protein Expression Inhibitors
Introduction
Masato Nakafuku is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of protein expression inhibitors. His work has implications for therapeutic applications in various diseases affecting the central nervous system.
Latest Patents
Masato Nakafuku holds a patent for "Numb protein expression inhibitors by Musashi." This invention comprises an active ingredient, Musashi protein, which is a polypeptide that has undergone modifications such as replacement, deletion, addition, or insertion of amino acids. The patent elucidates a new function of Musashi protein, which inhibits the expression of Numb protein, a key regulator of neuronal differentiation. This inhibition enhances the activity of the Notch signaling system, positioning Musashi protein as a potential therapeutic agent for central nervous system disorders. He has 1 patent to his name.
Career Highlights
Masato Nakafuku is affiliated with the Japan Science and Technology Corporation, where he continues to advance his research in protein expression and its applications. His innovative work has garnered attention in the scientific community, contributing to the understanding of protein functions in cellular processes.
Collaborations
Throughout his career, Nakafuku has collaborated with notable scientists, including Tetsu Yoshida and Katsuhiko Mikoshiba. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Masato Nakafuku's contributions to the field of biotechnology, particularly through his patent on Musashi protein expression inhibitors, highlight his role as an innovator. His work not only advances scientific knowledge but also opens new avenues for therapeutic interventions in neurological diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
